Heron Therapeutics HRTX Chief Operating Officer · filings 2025 to 2026
| Date | Transaction | Shares | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|
| Oct 30, 2026 | Option or RSU exercised or converted | +11,770 | 182,671 direct | Filing · EDGAR | ||
| Oct 30, 2026 | Shares withheld for tax or exercise price | −3,349 | $0.28 | $938 | 179,322 direct | Filing · EDGAR |
| Oct 30, 2026 | Option or RSU exercised or converted Restricted Stock Units | −11,770 | 153,006 direct | Filing · EDGAR | ||
| Aug 6, 2026 | Option or RSU exercised or converted | +31,250 | 179,789 direct | Filing · EDGAR | ||
| Aug 6, 2026 | Shares withheld for tax or exercise price | −8,888 | $0.50 | $4K | 170,901 direct | Filing · EDGAR |
| Aug 6, 2026 | Option or RSU exercised or converted Restricted Stock Units | −31,250 | 343,750 direct | Filing · EDGAR | ||
| Jul 31, 2026 | Option or RSU exercised or converted | +11,769 | 148,539 direct | Filing · EDGAR | ||
| Jul 31, 2026 | Option or RSU exercised or converted Restricted Stock Units | −11,769 | 164,776 direct | Filing · EDGAR | ||
| May 6, 2026 | Option or RSU exercised or converted | +125,000 | 136,770 direct | Filing · EDGAR | ||
| May 6, 2026 | Option or RSU exercised or converted Restricted Stock Units | −125,000 | 375,000 direct | Filing · EDGAR | ||
| Apr 30, 2026 | Option or RSU exercised or converted | +11,770 | 11,770 direct | Filing · EDGAR | ||
| Apr 30, 2026 | Option or RSU exercised or converted Restricted Stock Units | −11,770 | 176,545 direct | Filing · EDGAR | ||
| Jan 30, 2026 | Grant or award from the company Restricted Stock Units | +188,315 | 188,315 direct | Filing · EDGAR | ||
| Jan 30, 2026 | Grant or award from the company Performance Stock Units | +188,314 | 188,314 direct | Filing · EDGAR | ||
| May 6, 2025 | Grant or award from the company Restricted Stock Units | +500,000 | 500,000 direct | Filing · EDGAR |